Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-31

Clinical Trial Update: Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema [Phase 4]

View source ↗

Summary

A multicenter Phase 4 clinical trial assessing the efficacy and safety of Zarzenda in patients with hand eczema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zarzenda

Snippet

Sponsor: Bayer | Conditions: Hand Eczema | Phase 4 | Status: COMPLETED